| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 4,213.2 | 3,334.1 |
| Gross profit | 518.5 | 392.0 |
| Profit before tax | 129.4 | 49.6 |
| Net income | 100.1 | 55.8 |
| EPS (diluted, $ a share) | $0.45 | $0.26 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +79.3% |
|---|---|
| Revenue, year on year | +26.4% |
| Gross margin | 12.3% |
| Operating margin | 3.8% |
10-Q filed with the SEC, NASDAQ: BTSG. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
BrightSpring Health Services, Inc.: key numbers
- Share price
- $71.37Close, Nov 16
- Market cap
- $14.2B
- Shares outstanding
- 198.98MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Home Health Care ServicesSIC 8082
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from BrightSpring Health Services, Inc.
All →BrightSpring Health Services Financial Results
BrightSpring Health Services reported Q3 2026 net revenue of $4.21 billion, a 26.4% increase year-over-year, and net income from continuing operations of $101 million. Following the strong performance in its Pharmacy and Provider segments, the company increased its full-year 2026 revenue and Adjusted EBITDA guidance.
- Term
- Q3 2026
“Our third quarter results again reflect the commitment of our team to patient care and operational execution across our Pharmacy and Provider businesses. We have a differentiated company, our value proposition for healthcare stakeholders is clear, and our confidence in the future remains high, supported by a broad set of process and growth drivers across a uniquely scaled and high-quality platform.”
Jon Rousseau, Chairman, President, and Chief Executive Officer
BrightSpring Health Services President, PharMerica Scott A. Greenwell Sells $874K of Stock
Scott A. Greenwell, President, PharMerica, sold 15,099 shares of BrightSpring Health Services, Inc. at $57.91 a share, worth $874K in total on Sep 14, 2026. Shares held after the trade: 31,246 (-32.6%).
- Value
- $874K
- Shares
- 15,099
- Price
- $57.91
- Role
- President, PharMerica
- Holding change
- -32.6%
- Trade date
- Sep 14, 2026